News & Articles

The three companies will work to accelerate development of automated insulin delivery system for people living with diabetes

Watch this on-demand webinar to discover the role played by TGF-ß in the chronic immune reaction in severe cases of COVID-19

Findings suggest women with COVID-19 during pregnancy are five times more likely to be hospitalized, and six times as likely to require treatment in intensive care

Study in over 20,000 Canadian adults hospitalized with COVID-19 finds vaccination with at least one dose is linked with a significantly lower risk of ICU admission and death

Analysis of antimicrobial resistance in 271 US hospitals finds higher rates of antibiotic-resistant infections in both COVID-19 patients and SARS-COV-2 negative patients admitted during the pandemic compared to pre-pandemic

The report provides real-world treatment and outcome data for 850,000 US adults hospitalized with COVID-19 over 20 months of the pandemic

Trial results presented at ECCMID show potential of Actiphage for risk stratification in those with latent TB

Blood test could be used to identify patients most likely to become severely ill before they deteriorate

The researchers were able to build a decision tree to predict COVID-19 patients at risk of a poor prognosis

Nursery children were found to be exposed to the greatest variety of pathogens and the highest concentrations compared to other groups investigated

An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers

Blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease

SelectScience editors will be covering ECCMID 2022 so you can be sure not to miss out on top technology stories, product launches and latest research news from the event

Gibco CTS TrueCut Cas9 Protein supports use of genome editing for research and manufacturing applications, including CAR T-cell therapy research

The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation

In this article, you will find some of the pivotal research presented at the AACR annual meeting

The epigenomic signature is evident prior to CD19-targeted CAR T-cell treatment

Researchers have demonstrated that the adverse effects of combination therapy could be predicted

The identification of this genetic variant could help select lung cancer patients who may be at risk of more severe autoimmune side effects

An mRNA vaccine was combined with CAR T-cells that target tumor cells expressing the CLDN6 antigen

A study has shown that prostate-specific antigen (PSA) screening accuracy could be improved by accounting for genetic factors

the CAR-T therapy showed early signs of efficacy both as a monotherapy and in combination with CARVac in patients with testicular and other solid tumors

New instrument offers clinical flow cytometry laboratories robust and reliable immunophenotyping

The XQ-320 is a robust device, with low demands for sample volume, bench space, and maintenance